rs16826534

Variant summary

Our verdict is Benign. The variant received -15 ACMG points: 0P and 15B. BP4_ModerateBP6_Very_StrongBP7BS2

The NM_001791.4(CDC42):​c.276C>T​(p.Asn92Asn) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00142 in 1,607,852 control chromosomes in the GnomAD database, including 5 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.00089 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0015 ( 5 hom. )

Consequence

CDC42
NM_001791.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 2.41

Publications

2 publications found
Variant links:
Genes affected
CDC42 (HGNC:1736): (cell division cycle 42) The protein encoded by this gene is a small GTPase of the Rho-subfamily, which regulates signaling pathways that control diverse cellular functions including cell morphology, migration, endocytosis and cell cycle progression. This protein is highly similar to Saccharomyces cerevisiae Cdc 42, and is able to complement the yeast cdc42-1 mutant. The product of oncogene Dbl was reported to specifically catalyze the dissociation of GDP from this protein. This protein could regulate actin polymerization through its direct binding to Neural Wiskott-Aldrich syndrome protein (N-WASP), which subsequently activates Arp2/3 complex. Alternative splicing of this gene results in multiple transcript variants. Pseudogenes of this gene have been identified on chromosomes 3, 4, 5, 7, 8 and 20. [provided by RefSeq, Apr 2013]
CDC42 Gene-Disease associations (from GenCC):
  • macrothrombocytopenia-lymphedema-developmental delay-facial dysmorphism-camptodactyly syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, ClinGen, Ambry Genetics, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -15 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.34).
BP6
Variant 1-22086536-C-T is Benign according to our data. Variant chr1-22086536-C-T is described in ClinVar as Benign. ClinVar VariationId is 730778.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=2.41 with no splicing effect.
BS2
High AC in GnomAd4 at 135 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CDC42NM_001791.4 linkc.276C>T p.Asn92Asn synonymous_variant Exon 4 of 6 ENST00000656825.1 NP_001782.1 P60953-2A0A024RAA5
CDC42NM_001039802.2 linkc.276C>T p.Asn92Asn synonymous_variant Exon 5 of 7 NP_001034891.1 P60953-2A0A024RAA5
CDC42NM_044472.3 linkc.276C>T p.Asn92Asn synonymous_variant Exon 4 of 6 NP_426359.1 P60953-1A0A024RAA6

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CDC42ENST00000656825.1 linkc.276C>T p.Asn92Asn synonymous_variant Exon 4 of 6 NM_001791.4 ENSP00000499457.1 P60953-2
ENSG00000289694ENST00000695856.1 linkc.276C>T p.Asn92Asn synonymous_variant Exon 4 of 6 ENSP00000512221.1

Frequencies

GnomAD3 genomes
AF:
0.000875
AC:
133
AN:
152086
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000459
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000983
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00327
Gnomad SAS
AF:
0.000415
Gnomad FIN
AF:
0.0000944
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.00107
Gnomad OTH
AF:
0.00239
GnomAD2 exomes
AF:
0.00121
AC:
301
AN:
249510
AF XY:
0.00121
show subpopulations
Gnomad AFR exome
AF:
0.000630
Gnomad AMR exome
AF:
0.000847
Gnomad ASJ exome
AF:
0.000398
Gnomad EAS exome
AF:
0.00289
Gnomad FIN exome
AF:
0.0000926
Gnomad NFE exome
AF:
0.00148
Gnomad OTH exome
AF:
0.00198
GnomAD4 exome
AF:
0.00147
AC:
2143
AN:
1455648
Hom.:
5
Cov.:
29
AF XY:
0.00148
AC XY:
1071
AN XY:
723608
show subpopulations
African (AFR)
AF:
0.00135
AC:
45
AN:
33310
American (AMR)
AF:
0.00112
AC:
50
AN:
44464
Ashkenazi Jewish (ASJ)
AF:
0.000269
AC:
7
AN:
26070
East Asian (EAS)
AF:
0.00276
AC:
109
AN:
39556
South Asian (SAS)
AF:
0.000757
AC:
65
AN:
85834
European-Finnish (FIN)
AF:
0.000112
AC:
6
AN:
53384
Middle Eastern (MID)
AF:
0.00208
AC:
12
AN:
5756
European-Non Finnish (NFE)
AF:
0.00157
AC:
1741
AN:
1107138
Other (OTH)
AF:
0.00180
AC:
108
AN:
60136
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.453
Heterozygous variant carriers
0
86
172
258
344
430
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
70
140
210
280
350
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000887
AC:
135
AN:
152204
Hom.:
0
Cov.:
32
AF XY:
0.000739
AC XY:
55
AN XY:
74404
show subpopulations
African (AFR)
AF:
0.000506
AC:
21
AN:
41540
American (AMR)
AF:
0.000982
AC:
15
AN:
15278
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00328
AC:
17
AN:
5186
South Asian (SAS)
AF:
0.000415
AC:
2
AN:
4820
European-Finnish (FIN)
AF:
0.0000944
AC:
1
AN:
10594
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.00107
AC:
73
AN:
67992
Other (OTH)
AF:
0.00236
AC:
5
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.494
Heterozygous variant carriers
0
7
14
21
28
35
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00143
Hom.:
1
Bravo
AF:
0.000941
Asia WGS
AF:
0.00260
AC:
9
AN:
3478
EpiCase
AF:
0.00169
EpiControl
AF:
0.00119

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Feb 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

CDC42: BS1, BS2 -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.34
CADD
Benign
13
DANN
Benign
0.71
PhyloP100
2.4
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
2.7
Mutation Taster
=96/4
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs16826534; hg19: chr1-22413029; API